Presentation for the Fiscal Year Ended March 31, 2022

May 25, 2022

This datum is based on the data as of March 31, 2022. The opinion and forecast described here is based on our judgment at that time and may possibly be changed without notice.

  1. Operation results for FY2022
  2. FY2023 earning forecast
  3. General Condition
  4. Strengthen profit structure
  5. The situation of focus markets(Auto, Medical, Standard products)
  6. The background of choosing standard division
    • Summary

1

1. Summary of Consolidated Financial Results for Fiscal Year Ended Mar 2022

Million yen

FY2021

FY2022

Change

Change Ratio

Amount

Net Sales

19,539

21,722

2,182

11.2%

Operating

176

148

(27)

(15.7%)

Income

(Margin)

0.9%

0.7%

-

-

Ordinary

359

354

(4)

(1.2%)

Income

Net Income

633

(82)

(715)

-

Attribute to owners

of parent

FY2021

US$106.2 JPY

2

FY2022

US$112.9 JPY

1. Highlight

  • Net sales increased year on year due to a recovery in demand for automotive and medical applications compared to the previous fiscal year, when the impact of the Corona crisis was significant. However, opportunity losses were also incurred in automobile applications, affected by production cutbacks due to a shortage of semiconductors and parts.
  • Operating income declined YoY due to the aforementioned opportunity loss and the recording of expenses associated with the relocation of a US subsidiary's plant, an increase in project start-up costs at a Mexican subsidiary, and utility costs such as raw materials and logistics.
  • Ordinary income declined slightly year on year, despite foreign exchange gains.
  • Net income fell sharply compared with the previous fiscal year, when the company recorded a gain on the sale of its California plant. This was mainly due to an extraordinary loss associated with the relocation of its U.S. subsidiary's Tennessee plant.

3

1. Quarterly Transition of Sales and Income(Consolidated)

Million yen

Net Sales(Left axis)

Operationg

Income(Right axis)

Million yen

6,000

5,457

5,666

5,439

5,540

500

5,322

5,432

5,375

5,330

5,412

5,150

316

4,680

122

146

156

3,736

104

66

32

49

27

3,000

(36)

(72)

0

(329)

0

-500

1Q

2Q

3Q

4Q

1Q

2Q

3Q

4Q

1Q

2Q

3Q

4Q

FY20

FY21

FY22

4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Advanex Inc. published this content on 25 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 June 2022 13:42:02 UTC.